Protalix BioTherapeutics Inc. (DE) (PLX) Declined -6.38% or -0.03 To Price $0.47 On Monday


Protalix BioTherapeutics Inc. (DE) (PLX) declined -6.38% or -0.03 to $0.47. It is approximately 540541 shares traded, which is 187.53% compare to the average total volume 288244. The market cap of PLX is $69.46 million. The year to date change is 40.68%. The 52 week price range is from $0.27 to $0.83. Price of PLX have changed 37.40% during last week. It have changed 19.65% over last month, 9.87% over last 3 months, 19.02% over last 6 months and 8.44% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PLX is 0.42. It is -10.64% below current price. The 200-day Moving Averages for PLX is 0.46. It is -2.13% below current price. The 52-week High is 0.83. It is 76.60% from the current price. The 52-week Low is 0.27. It is -42.55% from current price.

There are some statistics of PLX. It is has market cap $69.46 million. The share outstanding is 148.38 million. The average volume is 288244. The percent of top 15 Institution holding is 13.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PLX is 55.30%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PLX is -44.11%.


Tags:

Share this post